The organisation keeps the right to make changes to the program at any time.
-
08:00
Investors forum part 1 - breakfast session -
Hosted by Johnson & Johnson Innovation
The investors forum is an exciting opportunity for those companies looking for equity capital and/or partnerships with companies and institutes across the life sciences value chain, from biotech, medtech and pharma companies to financiers and universities. The forum offers excellent opportunities for presenting your company or university to Venture Capitalists, corporate- and regional investment funds and to discuss your business strategy.
-
08:30
Present your company, products, technology or service. Open from 08:30 a.m. till 18:30 a.m.
-
09:30
Hosted by Leiden Bio Science Park
Welcome by our conference host Suzanne Spliethoff MSc. and official opening.
-
by Esther Peters, Director Leiden Bio Science Park
-
Jasper Levink, newly appointed CEO of Khondrion, will share his vision for leading the company’s next phase of growth in mitochondrial medicine. Building on a strong scientific foundation and clinical pipeline, he will outline priorities for advancing therapies to patients, fostering collaborations across the life sciences sector, and scaling Khondrion’s impact in rare disease innovation in the Netherlands and beyond.
-
Hosted by Health~Holland
The winner of the Venture Challenge Fall 2025 will be announced. Meet the six teams!
-
-
10:35
Time for networking and to visit the exhibition.
-
11:15
Parallel morning sessions
Biotech Booster: Showcasing Early-stage Projects
Hosted by Biotech Booster
Pitches by
▪ NanoLoom
▪ Constellate Proteomics
▪ ProliSpot
▪ On-site Readout of Chips for Infectious Disease Diagnostics (ORCHIDD)
▪ LumoxAI-powered Drug Discovery: from Bench to Computer
Presentations by
▪ Prof. Emeritus Barend Mons, Scientific Director and Chairman at LIFES
▪ Dr. Kanin Wichapong, CTO at Hillmark Biopharma
▪ Dr. Michael Rademaker, AI Solution Lead at Johnson & Johnson Innovative Medicine
▪ Max Trauernicht, co-founder VoyagenInnovations in Biologicals: from Concept to Cure
Hosted by Progress - Experts in Life Sciences
Presentations by
▪ Steven de Maat, Chief Scientific Officer & Co Founder TargED Biopharmaceuticals
▪ Wim Dokter PhD, Chief Scientific Officer at Byondis
▪ Ivan Burkov, Partner Inkef -
12:30
Time for networking and to visit the exhibition.
-
13:00
-
14:00
Parallel afternoon sessions
Innovations in Drug Delivery Technology
Hosted by LIFE Cooperative
Presentations by
▪ Prof. dr. Patrick van Rijn, Professor Translational & Regenerative Biomaterials at UMCG
▪ Rob Steendam, Chief Technology Officer at InnoCore Pharmaceuticals
▪ Dr. Ester Weijers, CEO Ntrans TechnologiesFrom Innovation to Market: Trends, Challenges and Lessons Learned in Diagnostics
Hosted by Thermo Fisher Scientific
Presentations by
▪ Dr. Anna Ressa, Manager Thematic Cluster 4 – Diagnostics and Services at Biotech Booster
▪ Sophia Shanko PhD, Founder and CEO ShanX Medtech
▪ Ing. Robert Olthuis, Accountmanager at The Binding Site (part of Thermo Fisher Scientific) and Boardmember Diagned (Dutch IVD Association)Licensing Success: Navigating Technology Transfer for Startups
Hosted by Axon Lawyers
Presentations and panel discussion with:
▪ Robert Al, Director Technology Transfer Office Erasmus MC
▪ Anouschka Versleijen, Director LURIS - Knowledge Transfer Office Leiden University
▪ Tessa Scharringhausen, Director Utrecht Holdings -
15:15
Time for networking and to visit the exhibition.
-
16:00
-
Wrap up the conference, together with feedback from the audience.
-
Announcement winner Investors Forum
The winner of the Investors Forum will be awarded a partnering ticket (value EUR 2,500) and present their winning pitch.
-
´Placebo effects: from psychobiological underpinnings to novel clinical applications´
Keynote presentation by Stefanie Meeuwis, Assistant Professor Tilburg University / Center for Interdisciplinary Placebo Studies Leiden (IPS)
Placebo effects are beneficial treatment outcomes, such as reduced pain, that are evoked by the context in which a treatment is provided. Stefanie’s keynote will focus on how a deeper understanding of these fascinating phenomena can help us design more effective treatments, enhance patient care, and responsibly harness their power to improve health and wellbeing.
-
´From investment banker to biotech entrepreneur´
Closing keynote presentation by Ilan Ganot, CEO Alesta Therapeutics
From investment banker to biotech entrepreneur, Ilan Ganot’s journey is fuelled by a deeply personal drive to turn science into hope for patients. As co-founder of Solid Biosciences in Boston and now CEO of Alesta Therapeutics in Leiden, he reflects on the challenges, lessons, and inspiration drawn from building companies in two very different life sciences ecosystems. His story is one of resilience, vision, and the belief that innovation can change lives.
-
-
17:15
Drinks, bites, networking and visit the exhibition!
-
18:30